跳至主要内容
临床试验/NL-OMON25628
NL-OMON25628招募中不适用

A randomised controlled trial comparing endometrial ablation plus levonorgestrel releasing intrauterine system versus endometrial ablation alone in women with heavy menstrual bleeding (MIRA 2 trial).

Máxima Medical Centre0 个研究点目标入组 718 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
718

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Women suffering from heavy menstrual bleeding, who do not wish or benefit from another treatment for heavy menstrual bleeding (medication or LNG-IUS) and opt for treatment with EA, irrespective of the existence of fibroids, polyps or adenomyosis. Earlier use of LNG-IUS is no exclusion.

排除标准

  • Women who don’t speak Dutch or English to a standard that they can fully understand the study and complete the trial questionnaires.
  • Women who might want to get pregnant in the future will not be included since an endometrium ablation interferes with future pregnancies.
  • Suspicion on endometrial cancer.
  • Contra-indications for levonorgestrel IUD.
  • Already performed Eandometrial Ablation.

研究者

发起方
Máxima Medical Centre

相似试验

A randomised controlled trial comparing endometrial... | 临床试验